Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.925
Delayed Data
As of 3:59pm ET
 -0.0255 / -2.68%
Today’s Change
0.72
Today|||52-Week Range
4.45
-9.31%
Year-to-Date
No recent news for Interpace Diagnostics Group Inc.

Today’s Trading

Previous close0.95
Today’s open0.97
Day’s range0.92 - 0.97
Volume214,615
Average volume (3 months)847,525
Market cap$25.5M
Data as of 3:59pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)+75.05%
Earnings growth (this year)+13.61%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+38.73%
P/E ratio0.3
Price/Sales0.61
Price/Book0.32

Competitors

 Today’s
change
Today’s
% change
BMRABiomerica Inc+0.11+2.64%
TRILTrillium Therapeutic...-0.15-2.08%
APHBAmpliPhi Biosciences...+0.11+9.02%
GALTGalectin Therapeutic...-0.06-1.38%
Data as of 4:00pm ET, 02/20/2018

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$13.1M
Annual profit (last year)-$9.7M
Net profit margin-64.27%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Jack E. Stover
Senior Vice President-
Operations
Glenn Gershon
Corporate headquarters
Parsippany, New Jersey

Forecasts